Rybelsus (oral GLP-1 | 1 tablet daily) - Includes shipping and consultation fees

Rybelsus (semaglutide) is the world's first oral GLP-1 receptor agonist.

It naturally controls food intake by suppressing appetite and maintaining a feeling of fullness, thus supporting weight loss. It is also expected to improve blood sugar levels.
Continued use can lead to greater weight loss.

Take once daily on an empty stomach after waking up.

Take with about half a glass (approx. 120 mL or less) of water,and avoid food, drink, and other medications for 30 minutes after taking.

Typically,start with 3 mgand after taking for at least 4 weeks, you can increase the dose to 7 mg or 14 mg.

Take at approximately the same time each day.

The displayed price includes the consultation fee and medication costs.

Common Side Effects

・Nausea
・Vomiting
・Diarrhea
・Constipation
・Abdominal pain
・Loss of appetite

These often appear at the beginning of treatment or when the dosage is increased, and may subside with continued use.

If you experience severe abdominal pain or persistent vomiting, stop taking the medication and seek medical attention immediately.

・Take on an empty stomach.
・Avoid eating, drinking, and taking other medications for 30 minutes after administration.
・Taking with a large amount of water may reduce drug absorption and may not provide sufficient efficacy.
・Do not use if you are pregnant, breastfeeding, or planning to become pregnant.
・Patients using other diabetes medications should be careful of hypoglycemia.

The following individuals should not use this product:

・Those with a history of hypersensitivity (allergy) to any ingredient in this product
・Pregnant or breastfeeding individuals
・Those for whom a doctor has determined use to be inappropriate

At our clinic, you can choose between "Standard Delivery (Nekoposu)" or "Takkyubin Compact (+500 yen)" depending on the size of your package and your preference.

Standard Delivery (Nekoposu)
Delivered via mailbox.
You can receive it even if you are not home.
Delivery date and time cannot be specified.

Takkyubin Compact (+500 yen)
Received in person.
Delivery date and time can be specified.
Even after shipping, you can change the delivery date/time or the pick-up location to a sales office, convenience store, etc.

For more details on shipping methods, please refer to "About Delivery".

*Depending on the order content and quantity of products, we may change to the most suitable shipping method. In such cases, no additional shipping fees will be incurred.

・Name: Rybelsus Tablets
・Generic name: Semaglutide
・Manufacturer and distributor: Novo Nordisk Pharma Ltd.

〈Unapproved drugs, etc. (use for different purposes)〉
Under the Pharmaceuticals and Medical Devices Act, this drug is approved for the indication and efficacy of type 2 diabetes. However, its use for obesity treatment, as performed at our clinic, is not approved in Japan.

〈Procurement channels, etc.〉
We procure domestically approved drugs from domestic pharmaceutical wholesalers.

〈Availability of domestically approved drugs〉
There are GLP-1 preparations approved for manufacture and sale in Japan for the indication and efficacy of obesity treatment.

〈Information on safety, etc., in other countries〉
Injectable GLP-1 receptor agonists are approved as obesity treatments by the U.S. FDA.